Rapid turnover serum proteins in fulminant hepatitis

Area of Science:

• Hepatology
• Biochemistry
• Clinical Diagnostics

Background:

• Acute viral hepatitis can lead to fatal outcomes.
• Early identification of patients at high risk of mortality is crucial for timely intervention.
• Serum proteins with rapid turnover are potential biomarkers for disease prognosis.

Purpose of the Study:

• To identify reliable serum protein indices for the early diagnosis of fatal acute viral hepatitis.
• To evaluate prealbumin, alpha2-HS-glycoprotein, and Normotest as prognostic markers.

Main Methods:

• Serum protein levels (prealbumin, alpha2-HS-glycoprotein, Normotest) were measured in 78 acute viral hepatitis patients.
• Measurements were taken before the onset of hepatic coma or gastrointestinal bleeding.
• Cases were verified by biopsy or necropsy.

Main Results:

• Prealbumin levels did not show a statistically significant difference between fatal and surviving cases.
• Alpha2-HS-glycoprotein levels were significantly lower in fatal cases (21.9 mg/dl) compared to surviving cases (37.4 mg/dl).
• Normotest values were significantly depressed in fatal cases (10.7%) versus surviving cases (45.3%).

Conclusions:

• Reduced levels of alpha2-HS-glycoprotein and Normotest can help differentiate between fatal and surviving cases of acute viral hepatitis at an early stage.
• These markers offer potential for early prognostic assessment in acute viral hepatitis.
• Further research may validate these findings for clinical application in predicting hepatitis outcomes.